Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

NCT07727694 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT07727694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07727694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2026
Completion date
December 31, 2030
Enrollment
1,600 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer